Thioredoxin-Interacting Protein Deficiency Protects against Diabetic Nephropathy.

Area of Science:

• Nephrology
• Molecular Biology
• Diabetology

Background:

• High glucose (HG) upregulates thioredoxin-interacting protein (TxNIP), an inhibitor of thioredoxin, exacerbating oxidative stress.
• Previous studies showed TxNIP-deficient mesangial cells are protected from HG-induced damage.

Purpose of the Study:

• To investigate the in vivo role of TxNIP in the pathogenesis of diabetic nephropathy (DN).

Main Methods:

• Diabetic wild-type (WT), TxNIP(-/-), and TxNIP(+/-) mice were induced using streptozotocin.
• Kidney function, histology, oxidative stress markers, inflammation, and podocyte integrity were assessed.
• In vitro studies used cultured human podocytes exposed to HG with TxNIP knockdown via siRNA.

Main Results:

• TxNIP(-/-) mice showed no increase in albuminuria, proteinuria, or kidney dysfunction markers compared to WT diabetic mice.
• Diabetic WT mice exhibited thickened glomerular basement membranes, effaced podocytes, increased glomerular TGF-β1, collagen IV, fibrosis, oxidative stress, and inflammation, which were absent in TxNIP(-/-) mice.
• TxNIP knockdown in human podocytes prevented HG-induced mitochondrial dysfunction and apoptosis.

Conclusions:

• TxNIP plays a critical role in the development and progression of diabetic nephropathy.
• TxNIP is a potential therapeutic target for managing DN.